Form D · Other Technology

vivo-TIL Therapeutics, Inc

Seattle, WA · CIK 0001727113

Offering snapshot reported Jan 5, 2018 · SEC filing

Reported sold
$990K
Offering amount: $990K
Investors reported
8
Form D · investor count
Minimum accepted
$5
Reported outside-investor minimum
First sale
Dec 21, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$495K$990KJan 4, 2018: $940,000.00Jan 4, 2018Jan 5, 2018: $990,000.00Jan 5, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$940,000 → $990,000
  • Reported investors7 → 8

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 5, 2018Amendment$990,000$50,000vs Jan 4, 20188SEC filing
Jan 4, 2018Initial$940,000No comparison7SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-302403

Source: Form D, filed Jan 5, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Laurie O Beitz Executive
Whitney Leibow Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
454 N 34 Th St
Seattle, WA, 98103